US 9125833
Multimodal abuse resistant and extended release opioid formulations
granted A61KA61K31/44A61K9/485
Quick answer
US patent 9125833 (Multimodal abuse resistant and extended release opioid formulations) held by Relmada Therapeutics, Inc. expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relmada Therapeutics, Inc.
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/44, A61K9/485, A61K9/4858, A61K9/4866